Sale!

COX15 Gene Cardioencephalomyopathy Fatal Infantile Due to Cytochrome C Oxidase Deficiency Type 2 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The COX15 gene cardioencephalomyopathy fatal infantile due to cytochrome c oxidase deficiency type 2 is a rare genetic disorder characterized by severe multi-organ dysfunction that primarily affects the heart and brain. This condition is caused by mutations in the COX15 gene, which plays a critical role in the assembly of cytochrome c oxidase, an essential component of the mitochondrial respiratory chain responsible for energy production in cells.

Patients with this disorder typically present with symptoms early in life, including hypertrophic cardiomyopathy, lactic acidosis, and neurodevelopmental delay, leading to early infantile death. Diagnosis of this condition relies on genetic testing to identify mutations in the COX15 gene.

In the United Arab Emirates, DNA Labs UAE offers a specialized genetic test for diagnosing this condition. The test costs 4400 AED and involves analyzing the patient’s DNA to detect mutations in the COX15 gene. This genetic test is crucial for confirming the diagnosis, allowing for appropriate management and counseling of affected families. DNA Labs UAE is equipped with advanced technology and expertise to provide accurate and reliable results for this complex genetic test.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

COX15 Gene Cardioencephalomyopathy Fatal Infantile Genetic Test

Welcome to DNA Labs UAE, where we offer the COX15 Gene Cardioencephalomyopathy fatal infantile due to cytochrome c oxidase deficiency type 2 Genetic Test. This test is designed to diagnose and provide information about a rare genetic disorder characterized by a deficiency in the enzyme cytochrome c oxidase (COX), which is crucial for the proper function of mitochondria in cells.

Test Details

The COX15 gene cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 2 Genetic Test utilizes NGS technology, which stands for next-generation sequencing. This high-throughput method allows for the simultaneous analysis of multiple genes. In the context of COX15 gene cardioencephalomyopathy, NGS genetic testing can identify mutations or variants in the COX15 gene associated with the disorder.

Components and Price

  • Test Name: COX15 Gene Cardioencephalomyopathy fatal infantile due to cytochrome c oxidase deficiency type 2 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cardiovascular Pneumology Disorders
  • Doctor: Cardiologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the COX15 Gene Cardioencephalomyopathy fatal infantile due to cytochrome c oxidase deficiency type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with COX15 Gene Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 2 NGS Genetic DNA Test gene COX15.

Importance of the Test

COX15 gene cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 2 is a rare genetic disorder that affects the heart and brain. The deficiency in the enzyme cytochrome c oxidase can lead to a wide range of symptoms. By analyzing the patient’s DNA, the NGS genetic testing can confirm a diagnosis, identify the specific genetic mutation causing the disorder, and provide information about the inheritance pattern. This information is crucial for understanding the disease, predicting the prognosis, and guiding treatment options or genetic counseling for affected individuals and their families.

Test Name COX15 Gene Cardioencephalomyopathy fatal infantile due to cytochrome c oxidase deficiency type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for COX15 Gene Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COX15 Gene Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 2 NGS Genetic DNA Test gene COX15
Test Details

COX15 gene cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 2 is a rare genetic disorder characterized by a deficiency in the enzyme cytochrome c oxidase (COX), which is essential for the proper function of mitochondria in cells. This deficiency leads to a wide range of symptoms affecting the heart and brain.

NGS genetic testing refers to next-generation sequencing, a high-throughput method used to analyze multiple genes simultaneously. In the context of COX15 gene cardioencephalomyopathy, NGS genetic testing can be used to identify mutations or variants in the COX15 gene that are associated with the disorder.

By analyzing the patient’s DNA, NGS genetic testing can help confirm a diagnosis, identify the specific genetic mutation causing the disorder, and provide information about the inheritance pattern. This information can be crucial for understanding the disease, predicting the prognosis, and potentially guiding treatment options or genetic counseling for affected individuals and their families.